A Phase 3 Study of Rusfertide in Patients With Polycythemia Vera
Clinical trial NCT05210790 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05210790
- Sponsor
- Protagonist Therapeutics, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-01
- Primary completion
- 2025-02-21
- Enrollment
- 293
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.